Immunoglobulin variable-region gene usage in systemic autoimmune diseases

Arthritis and Rheumatism

Volumn 44, Issue 12, 2001, Pages 2715-2727

  Dörner, Thomas ^a   Lipsky, Peter E ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION;

EID: 0035677577     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200112)44:12<2715::AID-ART458>3.0.CO;2-L     Document Type: Review

References (116)

1. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
2. Somatic generation of antibody diversity
3. Preferential expansion and survival of B lymphocytes based on VH framework 1 and framework 3 expression: "Positive" selection in appendix of normal and VH-mutant rabbits
4. Pairing of variable heavy and variable kappa chains in individual naive and memory B cells
5. Molecular and cellular origins of B lymphocyte diversity
6. Burnet's unhappy hybrid
7. Analysis of the heavy chain repertoire of human peripheral blood B cells using single-cell polymerase chain reaction
8. Analysis of the human VH gene repertoire: Differential effects of selection and somatic hypermutation on peripheral CD5+/IgM+ and CD5-/IgM+ B cells
9. Molecular mechanisms and selection influence the generation of the human VλJλ repertoire
10. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells
11. The human immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments
12. The human immunoglobulin lambda variable (IGKL) genes and joining (IGLJ) segments
13. The human immunoglobulin heavy variable genes
14. High-frequency representation of a single VH gene in the expressed human B cell repertoire
15. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas
16. Usage of a novel class of germline immunoglobulin variable region genes for cationic anti-DNA autoantibodies in human lupus nephritis and its role for the development of the disease
17. Nonstochastic utilization of Ig V region genes in unselected human peripheral B cells
18. Analysis of the VH3 repertoire among genetically disparate individuals
19. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells
20. Heavy-chain directed B-cell maturation: Continuous clonal selection beginning at the pre-B cell stage
21. B cell superantigens: Possible roles in immunodeficiency and autoimmunity
22. Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity
23. Comparable impact of mutational and selective influences in shaping the expressed repertoire of peripheral IgM+/CD5- and IgM+/CD5+ B cells
24. CD5-positive B cells in healthy elderly humans are a polyclonal B cell population
25. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire
26. The VλJλ repertoire in human fetal spleen: Evidence for positive selection and extensive receptor editing
27. Somatic mutations in the variable regions of human IgG anti-double stranded DNA antibodies suggest a role for antigen in the induction of SLE
28. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation
29. Origins of anti-DNA antibodies and their implications for B-cell tolerance
30. Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA
31. V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice
32. Lifetime of plasma cells in the bone marrow
33. Memory B-cell persistence is independent of persisting immunizing antigen
34. Disturbed peripheral B lymphocyte homeostasis
35. H genes
36. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus
37. Immunoglobulin lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation
38. κ light chain gene analysis in patients with Sjögren's syndrome
39. λ light chain gene usage in patients with Sjögren's syndrome
40. Use of immunoglobulin variable genes in normals and patients with systemic lupus erythematosus
41. Life and death in germinal centers (redux)
42. V(D)J recombinase activity in a subset of germinal center B lymphocytes
43. V(D)J recombination in mature B cells: A mechanism for altering antibody responses
44. Light chain editing in κ-deficient animals: A potential mechanism of B cell tolerance
45. Light chain replacement: A new model for antibody gene rearrangement
46. Receptor editing in selfreactive bone marrow B cells
47. Revising B cell receptors
48. RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood
49. Circulating human B cells that express surrogate light chains and edited receptors
50. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice
51. Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe
52. Receptor editing, immune diversification and self-tolerance
53. Characterization of a germline encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus
54. Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus
55. Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements
56. Editing disease-associated autoantibodies
57. Receptor editing: An approach by autoreactive B cells to escape tolerance
58. Analysis of V kappa I and V lambda II light chain genes in the expressed B cell repertoire
59. Analysis of the V kappa I family: Germline genes from an SLE patient and expressed autoantibodies
60. Lupus-specific antibodies reveal an altered pattern of somatic mutation
61. Repertoire cloning of lupus anti-DNA autoantibodies
62. The anti-DNA-associated idiotype 8.12 is encoded by the V lambda II gene family and maps to the vicinity of L chain CDR1
63. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis
64. Lupus/Sjögren's autoantibody specificities in sera with paraproteins
65. Molecular cloning of anti-SS-A/Ro 60 kDa peptide Fab fragments from infiltrating salivary gland lymphocytes of a patient with Sjögren's syndrome
66. Distinctive serologic, chemical, and molecular properties of human lambda IV light chains
67. Preferential utilization of a novel Vλ3 gene in monoclonal rheumatoid factors derived from the synovial cells of rheumatoid arthritis patients
68. Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: Auto- and multi-reactivity, diverse VH gene segment usage of Vλ IIIb
69. Chemical and serologic characterization of human lambda VIII light chains
70. H domains of five human IgM directed to lamin B: Evidence for an antigen-driven process in the generation of human autoantibodies to lamin B
71. The production, binding characteristics and sequence analysis of four human IgG monoclonal antiphospholipid antibodies
72. Light chain variable (VL) sequences of rheumatoid factors (RF) in patients with primary Sjogren's syndrome (pSS): Moderate contribution of somatic hypermutation
73. Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes
74. κ gene rearrangements in systemic lupus erythematosus
75. Comparable heavy and light chain pairings in normal and systemic lupus erythematosus IgG(+) B cells
76. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins: Evidence that the VH4-21 gene segment is responsible for the major cross reactive idiotype
77. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens
78. Evidence for the overexpression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire
79. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus
80. Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells
81. Immunglobulin variable gene usage in systemic autoimmune diseases
82. Immunoglobulin variable region sequences of human monoclonal anti-DNA antibodies
83. Three-dimensional structure of the Fab from a human IgM cold agglutinin
84. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis
85. Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with RA
86. Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE)
87. VH4-34 encoded antibodies in systemic lupus erythematosus: A specific diagnostic marker that correlates with clinical disease characteristics
88. Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus
89. Comparative characteristics of mu chain and alpha chain transcripts expressed by individual tonsil plasma cells
90. Antigendriven clonal proliferation of B cells within the target tissue of an autoimmune disease: The salivary glands of patients with Sjogren's syndrome
91. Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B
92. Harmful somatic mutations: Lessons from the dark side
93. Molecular characterization of a somatically mutated anti-DNA antibody bearing two systemic lupus erythematosus-related idiotypes
94. Mutational analysis of rearranged Ig V genes suggests two mechanisms of somatic hypermutation
95. DNA double strand breaks in immunoglobulin genes undergoing somatic hypermutation
96. The double edge sword of the immune response: Mutational analysis of a murine anti-pneumococcal anti-DNA antibody
97. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition
98. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease
99. Comparison of a monoclonal and polyclonal anti-idiotype against a human IgG anti-DNA antibody
100. VH-gene representation in autoantibodies reflects the normal human B-cell repertoire
101. The role of somatic mutation in the pathogenic anti-DNA response
102. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation
103. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement
104. H gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome
105. Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features
106. H gene rearrangements in systemic lupus erythematosus
107. It's not the same old lupus or Sjogren's any more: One hundred new insights, approaches, and options since 1990
108. Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire
109. Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements
110. κ rearrangements: Targeting of RGYW motifs on both DNA strands and preferential selection of mutated codons within RGYW motifs
111. λJλ gene rearrangements
112. Targeting of somatic hypermutation
113. The influence of CD40-CD154 interactions on the expressed human variable heavy chain repertoire: Analysis of VH genes expressed by individual B cells of a patient with X-linked hyper-IgM syndrome